No arguments for extra risk from ibuprofen in SARS-COV2 infection.

No arguments for extra risk from ibuprofen in SARS-COV2 infection. Therapie. 2020 Jul 11;: Authors: Moore N PMID: 32829912 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32829912?dopt=Abstract

Source: Therapie - July 10, 2020 Category: Psychiatry & Psychology Authors: Moore N Tags: Therapie Source Type: research

More News: Ibuprofen | Psychology | SARS